Jiangsu Lanfeng Bio-chemical (002513.SZ)'s application for a targeted issuance of shares to specific targets has been accepted by the Shenzhen Stock Exchange.
Jiangsu Lanfeng Bio-chemical (002513.SZ) announced that on November 12, 2026, the company received the "Notice on Accepting the Application Documents for Issuing Shares to Specific Targets by Jiangsu Lanfeng Bio-chemical Co., Ltd." issued by the Shenzhen Stock Exchange (the "SZSE"). The SZSE reviewed the application documents for the issuance of shares to specific targets submitted by the company, determined that the application documents were complete, and decided to accept them.
Jiangsu Lanfeng Bio-chemical (002513.SZ) announced that on November 12, 2026, the company received the "Notice on Accepting the Application Documents for Jiangsu Lanfeng Bio-chemical Co., Ltd.'s Targeted Issuance of Shares to Specific Targets" issued by the Shenzhen Stock Exchange (the "SZSE"). The SZSE reviewed the application documents for the targeted issuance of shares to specific targets submitted by the company, determined that the application documents were complete, and decided to accept them.
Related Articles
AI capex peaks, global equity earnings shift gears! Goldman Sachs outlines three major themes for 2027.
CHINAGOLDINTL (02099) Q3 sales revenue US$454 million, up 32% year on year
Jensen Huang is gonewhat happens to the US$500 billion financing platform? The "pillar of trust" underpinning NVIDIA Corporation (NVDA.US)'s AI credit platform is collapsing.
AI capex peaks, global equity earnings shift gears! Goldman Sachs outlines three major themes for 2027.
CHINAGOLDINTL (02099) Q3 sales revenue US$454 million, up 32% year on year
Jensen Huang is gonewhat happens to the US$500 billion financing platform? The "pillar of trust" underpinning NVIDIA Corporation (NVDA.US)'s AI credit platform is collapsing.
